Molecular Partners AG (MOLN)
3.80
-0.07
(-1.81%)
USD |
NASDAQ |
May 20, 16:00
3.80
0.00 (0.00%)
After-Hours: 16:55
Molecular Partners Total Return Level: 3.78 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 3.78 |
May 16, 2024 | 3.87 |
May 15, 2024 | 3.71 |
May 14, 2024 | 3.548 |
May 13, 2024 | 3.80 |
May 10, 2024 | 3.80 |
May 09, 2024 | 3.701 |
May 08, 2024 | 3.76 |
May 07, 2024 | 3.65 |
May 06, 2024 | 3.61 |
May 03, 2024 | 3.98 |
May 02, 2024 | 3.765 |
May 01, 2024 | 3.87 |
April 30, 2024 | 3.781 |
April 29, 2024 | 3.70 |
April 26, 2024 | 3.88 |
April 25, 2024 | 3.88 |
April 24, 2024 | 3.88 |
April 23, 2024 | 3.88 |
April 22, 2024 | 3.88 |
April 19, 2024 | 3.32 |
April 18, 2024 | 3.74 |
April 17, 2024 | 3.91 |
April 16, 2024 | 3.91 |
April 15, 2024 | 3.95 |
Date | Value |
---|---|
April 12, 2024 | 3.95 |
April 11, 2024 | 3.86 |
April 10, 2024 | 4.06 |
April 09, 2024 | 3.96 |
April 08, 2024 | 3.96 |
April 05, 2024 | 3.95 |
April 04, 2024 | 3.91 |
April 03, 2024 | 4.048 |
April 02, 2024 | 3.90 |
April 01, 2024 | 4.20 |
March 28, 2024 | 4.20 |
March 27, 2024 | 4.20 |
March 26, 2024 | 4.24 |
March 25, 2024 | 4.18 |
March 22, 2024 | 4.065 |
March 21, 2024 | 3.88 |
March 20, 2024 | 3.88 |
March 19, 2024 | 3.870 |
March 18, 2024 | 4.185 |
March 15, 2024 | 3.96 |
March 14, 2024 | 3.865 |
March 13, 2024 | 3.73 |
March 12, 2024 | 3.995 |
March 11, 2024 | 4.115 |
March 08, 2024 | 4.17 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
3.32
Minimum
Apr 19 2024
31.89
Maximum
Jan 14 2022
9.987
Average
6.54
Median
Jun 13 2022
Total Return Level Benchmarks
AC Immune SA | 3.18 |
CRISPR Therapeutics AG | 56.22 |
Addex Therapeutics Ltd | 8.79 |
NLS Pharmaceutics Ltd | 0.164 |
MoonLake Immunotherapeutics | 39.75 |